Sanofi MS Drug Tolebrutinib Misses Goal in Relapsing Disease Trials

By Ludwig Burger(Reuters) - Sanofi's most advanced multiple sclerosis (MS) drug candidate has missed the main goal of two late-stage trials to...

aldoguerra851@gmail.com aldoguerra851@gmail.com
Sep 2, 2024 - 01:32
71 0
By Ludwig Burger(Reuters) - Sanofi's most advanced multiple sclerosis (MS) drug candidate has missed the main goal of two late-stage trials to...
Read More